Ascendis Pharma Investigational Site

Chicago, Illinois 60637

0 studies enrolling now · 6 studies all time

What they study most

Adult Growth Hormone Deficiency, Advanced Solid Tumor, Endocrine System Diseases, Growth Hormone Deficiency, HPV-associated Cancers, Head and Neck Squamous Cell Carcinoma HNSCC, Hormone Deficiency, Hypoparathyroidism, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC), Neoadjuvant Melanoma

Studies at this site

• A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency — Completed
• A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism — Completed
• A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency — Completed
• A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism — Completed
• A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome — Running, not enrolling
• A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors — Stopped early